Recent Updates
Recently added Catalysts
NAUT Positive Sentiment

Iterative Mapping FAQ

Key Takeaway: Nautilus Biotechnology's Iterative Mapping is a groundbreaking method for quantifying proteins and proteoforms across the entire proteome. This technique utilizes single-molecule arrays and machine learning algorithms to achieve high sensitivity and reproducibility. Recent demonstrations have shown its effectiveness in quantifying tau proteoforms, and the company is actively seeking collaborations for research applications.
Price reaction · baseline $0.8902 (2025-10-09T15:40:00.000Z) · hit during market hours · clean, no other NAUT news in the window
day 0 close · peak
+1.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Iterative Mapping enables complete proteome coverage.
  • Single-molecule sensitivity enhances precision in quantification.
  • Demonstrated high reproducibility in quantifying tau proteoforms.
  • Early Access Program invites collaboration for research advancements.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~29 mo
Minimal dilution risk
Lead asset
MDMA
Phase 2 · Post-Traumatic Stress Disorder

Full Press Release Details

Nautilus and our Platform
Nautilus Biotechnology
October 9, 2025

What is Iterative Mapping?

Iterative Mapping is Nautilus’ novel method for quantifying proteins and proteoforms across the full proteome. In the method, billions of protein molecules are captured and displayed on massive, single-molecule arrays – one protein per optically distinguishable landing pad. Fluorescent probes that bind features indicative of protein or proteoform identity are sequentially added to the array, and multiple probe-protein binding events are recorded for every individual protein molecule. After tens to hundreds of unique probe binding cycles, machine learning-powered algorithms convert the probe binding patterns into confident protein and proteoform identifications that are summed for robust quantification.

What are the benefits of Iterative Mapping?

Unlike other methods, Iterative Mapping is designed to enable complete proteome coverage without compromising reproducibility, sensitivity and dynamic range due to:
• Single-molecule sensitivity and precision – other methods blur signals coming from many molecules and deliver rough estimates of abundance without the ability to identify proteoforms.
• Massive arrays capable of capturing the full proteome – other methods rarely quantify more than 50% of the proteome and often quantify different portions of the proteome in every sample.
• Multi-touch identifications compatible with diverse probe modalities that make quantitation accurate and reproducible – other methods make convoluted inferences about protein quantity from the detection of a few epitopes or peptides per protein yielding inaccurate and irreproducible protein quantifications.

Can you share examples demonstrating Iterative Mapping’s performance?

In our recent preprint , we demonstrated accurate, sensitive, precise, and highly reproducible quantitation of 130 tau proteoforms with just 12 probes. This work shows how all the components of our platform come together to quantify single-protein molecules and provide in-depth views of proteoform landscapes that cannot be seen on other platforms.
We regularly share updates on the application of Iterative Mapping to broadscale proteomics at conferences throughout the year. Access our US HUPO 2025 updates here – it features data demonstrating limited bias in protein library preparation, high sensitivity in protein quantification, and reproducibility in probe binding patterns.

When can I use Iterative Mapping in my work?

Please reach out to us if you’d like to use Iterative Mapping in your research, particularly if you’re interested in using our tau proteoform assay – we’re actively pursuing early-stage collaborations and would love to hear from you!
Join the Iterative Mapping Early Access Program to be one the first to use the Nautilus Platform in your research.
Share this Article
Stay up-to-date on all things Nautilus
World-class articles, delivered weekly
MORE ARTICLES
Nautilus: Driving a revolution in proteomic analysis
New protein sequencing technology from Nautilus is unlocking the proteome and igniting a proteomics revolution.
Read more
A brief introduction to PrISM – The theoretical framework underpinning the Nautilus platform
Learn about Protein Identification by Short epitope Mapping (PrISM) - The theoretical framework underpinning the Nautilus Platform.
Read more
Nautilus: Driving a revolution in proteomic analysis (Part 2)
We give you an inside view on how cross-disciplinary thinking and collaboration will propel us into a proteomics-powered future.
Read more
Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Frequently Asked Questions

What is Iterative Mapping?

Iterative Mapping is Nautilus' method for quantifying proteins across the full proteome using single-molecule arrays.

What are the benefits of Iterative Mapping?

It offers complete proteome coverage, single-molecule sensitivity, and accurate quantification.

How does Iterative Mapping perform in quantification?

It has demonstrated high sensitivity and reproducibility, accurately quantifying 130 tau proteoforms.

When can I use Iterative Mapping?

Reach out to Nautilus for collaboration opportunities, especially for the tau proteoform assay.

Last updated: Oct 9, 2025